October 19, 2021

Future-Proof Core Network, Gearing up Business Innovation

DUBAI, UAE, Oct. 19, 2021 /PRNewswire/ — The 5G Core Summit 2021 was successfully held recently. Richard Liu, President of Huawei Cloud Core Network Product Line, delivered a keynote speech titled “Future-Proof Core Network, Gearing up Business Innovation” at the summit. In his speech, Mr. Liu expanded on Huawei’s thoughts on the 5.5G core network […]

Milipol Paris 2021: ULBRICHTS Protection presents the first “stand alone” helmet capable of stopping Kalashnikov iron-core ammunition and reducing the back face deformation / trauma to below the fatal level of 25 joules

SCHWANENSTADT, Austria and PARIS, Oct. 19, 2021 /PRNewswire/ — ULBRICHTS achieves the breakthrough, opening up a new era in ballistic protective helmets with real protection against rifle: ULBRICHTS Protection presents its new RIFLE helmet family. The new VPAM 6 rifle helmet protects ‘stand alone’ on the surface without additional protective shields (FORTIS) against dangerous threats (7.62×39 MSC). The […]

EthosEnergy CEO Ana Amicarella recognized as Top Executive for 2021

San Antonio, Texas, Oct. 19, 2021 (GLOBE NEWSWIRE) — San Antonio, Texas – EthosEnergy’s CEO, Ana Amicarella has been recognized as Top Executive of the Year during the Experience Power conference hosted by Power magazine. Power magazine honored innovative leaders from the power generation industry during an awards ceremony at the Experience Power conference last […]

Adagio Therapeutics Announces New In Vitro Data Highlighting Broad and Potent Neutralization of ADG20 Against All Known SARS-CoV-2 Variants

Data to be presented at the 2021 ISIRV-WHO Virtual Conference WALTHAM, Mass., Oct. 19, 2021 (GLOBE NEWSWIRE) — Adagio Therapeutics, Inc., (Nasdaq: ADGI) a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of antibody-based solutions for infectious diseases with pandemic potential, today announced new in vitro data demonstrating retained neutralizing activity of its monoclonal antibody […]